The Patent Finder
US

Compositions Comprising Methylphenidate-Prodrugs, Processes of Making and Using the Same

US 11,505,537 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Sep 11, 2026 (Truist Bank).

Term ends Jul 27, 2032 · Low confidence

Filed Dec 8, 2020 as application 17/115,425 · Granted Nov 22, 2022
Base term plus 56 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
20 years from filing
2017 2037
Clock starts
Dec 9, 2017
Term ends
Jul 27, 2032
Granted
Nov 22, 2022
base term after the term ends fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
56
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 10,584,112, US 10,584,113, US 10,759,778, US 10,954,212, US 9,079,928.
1 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term runs 56 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 2 maintenance fees is paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 9, 2017, when application PCT/US2017/065482, the earliest non-provisional in its chain, was filed (this one was filed Dec 8, 2020); a parent in its chain could not be resolved (the next row)Dec 9, 2037High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustment+56 days, USPTO patent term adjustment recordFeb 3, 2038High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,584,112, US 10,584,113, US 10,759,778, US 10,954,212, US 9,079,928)capped to Jul 27, 2032Medium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 2 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderJul 27, 2032Low confidence

This family

US 10,584,113In force
no later than Dec 2037
no later than Dec 2037
US 10,584,112In force
no later than Dec 2037
no later than Dec 2037
US 10,759,778In force
Dec 2037
Dec 2037
US 11,021,459In force
Dec 2037
Dec 2037
US 11,021,460In force
Dec 2037
Dec 2037
US 10,954,212In force
Dec 2037
Dec 2037
US 10,954,213In force
Dec 2037
Dec 2037
US 10,858,341In force
Dec 2037
Dec 2037
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jan 14, 2021
Reel 54920, frame 66
Mickle, Travis; Guenther, Sven; Chi, GuochenKempharm, Inc.Assignment of Assignor's Interest
Apr 8, 2024
Reel 67040, frame 637
Zevra Therapeutics, Inc.Alter Domus (US) LLCSecurity Interest
Mar 13, 2026
Reel 75080, frame 907
Alter Domus (US) LLCZevra Therapeutics, Inc.Release of Security Interest
Mar 25, 2026
Reel 75243, frame 8
Kempharm, Inc.Zevra Therapeutics, Inc.Change of Name
Mar 25, 2026
Reel 74186, frame 531
Zevra Therapeutics, Inc.Commave Therapeutics S.A.Assignment of Assignor's Interest
Mar 26, 2026
Reel 74195, frame 8
Zevra Therapeutics, Inc.Commave Therapeutics S.A.Assignment of Assignor's Interest
Sep 11, 2026
Reel 75980, frame 787
Commave Therapeutics S.A.Truist Bank, As Administrative AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited